BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17096453)

  • 1. The cancer worry chart: a single-item screening measure of worry about developing breast cancer.
    Gramling R; Anthony D; Frierson G; Bowen D
    Psychooncology; 2007 Jun; 16(6):593-7. PubMed ID: 17096453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer worry in women with hereditary risk factors for breast cancer.
    Loescher LJ
    Oncol Nurs Forum; 2003; 30(5):767-72. PubMed ID: 12949589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer worry and mammography use by women with and without a family history in a population-based sample.
    Andersen MR; Smith R; Meischke H; Bowen D; Urban N
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):314-20. PubMed ID: 12692105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between screening family medical history in general medical care and lower burden of cancer worry among women with a close family history of breast cancer.
    Gramling R; Anthony D; Lowery J; Ballinger L; Ma D; Habbal R; Leighton N; Bowen D
    Genet Med; 2005; 7(9):640-5. PubMed ID: 16301866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer early detection, health beliefs, and cancer worries in randomly selected women with and without a family history of breast cancer.
    Cohen M
    Psychooncology; 2006 Oct; 15(10):873-83. PubMed ID: 16374894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing acculturation scales and their relationship to cancer screening among older Mexican-American women.
    Suarez L; Pulley L
    J Natl Cancer Inst Monogr; 1995; (18):41-7. PubMed ID: 8562221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
    van Dijk S; Timmermans DR; Meijers-Heijboer H; Tibben A; van Asperen CJ; Otten W
    J Clin Oncol; 2006 Aug; 24(22):3672-7. PubMed ID: 16877736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution of worry after breast cancer risk assessment: 6-year follow-up of the TRACE study cohort.
    Brain K; Parsons E; Bennett P; Cannings-John R; Hood K
    Psychooncology; 2011 Sep; 20(9):984-91. PubMed ID: 20677331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
    Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
    J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Flemish women in semi-rural areas be motivated to attend organized breast cancer screening?
    Van Hal G; Matthyssen M; Thibaut A; Weyler J
    Rev Epidemiol Sante Publique; 1999 Apr; 47(2):119-27. PubMed ID: 10367299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cancer Worry Scale: detecting fear of recurrence in breast cancer survivors.
    Custers JA; van den Berg SW; van Laarhoven HW; Bleiker EM; Gielissen MF; Prins JB
    Cancer Nurs; 2014; 37(1):E44-50. PubMed ID: 23448956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and psychometric testing of the coping with breast cancer threat instrument.
    Lancaster DR
    J Nurs Meas; 2004; 12(1):33-46. PubMed ID: 15916318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term cohort study of women at intermediate risk of familial breast cancer: experiences of living at risk.
    Bennett P; Parsons E; Brain K; Hood K;
    Psychooncology; 2010 Apr; 19(4):390-8. PubMed ID: 19514016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved screening for breast cancer associated with a telephone-based risk assessment.
    Kadison P; Pelletier EM; Mounib EL; Oppedisano P; Poteat HT
    Prev Med; 1998; 27(3):493-501. PubMed ID: 9612841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation in breast cancer risk counseling among women with a family history.
    Bowen D; McTiernan A; Burke W; Powers D; Pruski J; Durfy S; Gralow J; Malone K
    Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):581-5. PubMed ID: 10428194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a randomized study of telephone versus in-person breast cancer risk counseling.
    Helmes AW; Culver JO; Bowen DJ
    Patient Educ Couns; 2006 Dec; 64(1-3):96-103. PubMed ID: 16427245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
    Bober SL; Hoke LA; Duda RB; Regan MM; Tung NM
    J Clin Oncol; 2004 Dec; 22(24):4951-7. PubMed ID: 15598980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral prophylactic mastectomy decision making: A vignette study.
    Stefanek M; Enger C; Benkendorf J; Flamm Honig S; Lerman C
    Prev Med; 1999 Sep; 29(3):216-21. PubMed ID: 10479610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.